News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Policy
Therma Bright Provides 2022 Year End Update
December 21, 2022
·
8 min read
CVR Medical Corp. Announces Amended Restructuring Agreement with CVR Global, Inc.
December 20, 2022
·
6 min read
Breakthrough Results: Defence’s Novel AccuTOX(TM) Intranasal Reduced 50% of Cancer Nodules on Animals with Lung Tumors
December 20, 2022
·
5 min read
Drug Development
Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE
December 20, 2022
·
4 min read
Scryb Announces New Contract Win for Cybeats with Fortune 500 Industrial Technology Company
December 19, 2022
·
4 min read
Drug Development
InFlectis BioScience Doses First Patient with IFB-088 in a Phase 2 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
December 19, 2022
·
1 min read
Britannia Life Sciences Inc. Announces Results of Annual Meeting of Shareholders
December 16, 2022
·
3 min read
Drug Development
Skye Bioscience Doses First Cohort of Participants in Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion
December 16, 2022
·
5 min read
BioHarvest Sciences Inc. Projects 2023 Revenue to Grow 3.0X-3.5X to a Range of USD $17M-$20M
December 15, 2022
·
5 min read
Defence’s mRNA with Accum(TM) for Cancer Vaccines Update
December 15, 2022
·
4 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us